FDA solicits advisory committee nominations
FDA requests nominations to fill forthcoming vacancies on the Allergenic Products; Blood Products; Cellular, Tissue and Gene Therapies; Transmissible Spongiform Encephalopathies; and Vaccines and Related Products Advisory Committees. No cutoff date is established for the 14 anticipated positions; however, FDA asks that all nominations be received at least six months prior to the date of scheduled vacancy...
You may also be interested in...
Early results from its novel antiviral are encouraging, but demonstrating life-saving qualities in a short window of time will be tricky.
After federal agencies invested almost $5600m to ensure Cue Health could scale up production, FDA announces the self-administered test will be available OTC. it's the agency's first emergency use authorization for an at-home molecular diagnostic test available nonprescription.
Tezepelumab was among four products that the European Medicines Agency most recently considered for review under its accelerated assessment mechanism.